Ignite Creation Date:
2025-12-26 @ 3:59 PM
Ignite Modification Date:
2026-02-24 @ 5:05 AM
Study NCT ID:
NCT02412306
Status:
COMPLETED
Last Update Posted:
2022-12-12
First Post:
2015-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Sponsor:
Amgen
Organization: